You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis%20C%20Genotype%202

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

Active, not recruiting
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +9 more
    Mar 1, 2022

    Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 28, 2021

    Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

    Completed
    • Hepatitis C
    • Peginterferon alfa-2a
    • +2 more
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Aug 26, 2021

    Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

    Completed
    • Hepatitis C, Chronic
    • PEGASYS 180 µg Q1W
    • +3 more
    • Changhua, Taiwan
    • +12 more
    Oct 7, 2021

    Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

    Completed
    • Chronic Hepatitis c Genotype 1
    • Moscow, Russian Federation
    • +4 more
    Oct 27, 2022

    Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

    Completed
    Has Results
    • Chronic Hepatitis C Genotype 1
    • (no location specified)
    Jan 15, 2021

    Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

    Completed
    Has Results
    • Chronic Hepatitis C
    • Baltimore, Maryland
      Institute of Human Virology University of Maryland
    Apr 26, 2021

    Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

    Completed
    Has Results
    • Hepatitis C Infection
    • HIV Infection
    • Nitazoxanide With Pegylated Interferon And Ribavirin
    • Washington, District of Columbia
    • +3 more
    Sep 14, 2021

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

    Completed
    Has Results
    • Hepatitis C Virus (HCV)
    • San Diego, California
    • +24 more
    Jul 14, 2021

    Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

    Completed
    Has Results
    • Chronic Hepatitis C
    • (no location specified)
    Feb 28, 2021

    Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

    Completed
    • Chronic Hepatitis C Virus Infection
    • P1101 + Ribavirin
    • PEG-Intron + Ribavirin
    • Beijing, China
    • +38 more
    Jan 14, 2022

    Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

    Completed
    • Hepatitis C
    • HCV
    • San Antonio, Texas
      Texas Liver Institute
    Jan 15, 2021

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Chronic Hepatitis C Trial (Ravidasvir, Danoprevir, Ritonavir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • (no location specified)
    Oct 20, 2020